Molecular characterization and antimicrobial susceptibility patterns of Clostridium difficile strains isolated from hospitals in south-east Scotland

Journal of Medical Microbiology

Volumn 56, Issue 7, 2007, Pages 921-929

  Mutlu, Esvet ^a,c   Wroe, Allison J ^a   Sanchez Hurtado, Karla ^a   Brazier, Jon S ^b   Poxton, Ian R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^c Antalya E itim ve Ara tirma Hastanesi Infeksiyon Hastaliklari ve Klinik Mikrobiyoloji Klini i   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFTRIAXONE; CLINDAMYCIN; CLOSTRIDIUM TOXIN; ERYTHROMYCIN; FLAGELLIN; METRONIDAZOLE; MOXIFLOXACIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; CLOSTRIDIUM DIFFICILE; DNA EXTRACTION; FLIC GENE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR TYPING; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RESTRICTION MAPPING; RIBOTYPING; TOXIN SYNTHESIS; UNITED KINGDOM;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIAL TOXINS; BACTERIAL TYPING TECHNIQUES; CLOSTRIDIUM DIFFICILE; DRUG RESISTANCE, BACTERIAL; ENTEROCOLITIS, PSEUDOMEMBRANOUS; ENTEROTOXINS; FLAGELLIN; GENOTYPE; HOSPITALS; HUMANS; MEMBRANE GLYCOPROTEINS; MICROBIAL SENSITIVITY TESTS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RIBOTYPING; SCOTLAND;

EID: 34447263018     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.47176-0     Document Type: Article

References (47)

1. Ackermann, G., Tang, Y. J., Kueper, R., Heisig, P., Rodloff, A. C., Silva, J. & Cohen, S. H. (2001). Resistance to moxifloxacin in toxigenic Clostridium difficile isolates is associated with mutations in gyrA. Antimicrob Agents Chemother 45, 2348-2353.
2. B) resistance with resistance to moxifloxacin in Clostridium difficile. J Antimicrob Chemother 51, 599-603.
3. Alonso, R., Martin, A., Peláez, T., Marín, M., Rodríguez-Creixéms, M. & Bouza, E. (2005). Toxigenic status of Clostridium difficile in a large Spanish teaching hospital. J Med Microbiol 54, 159-162.
4. Aspevall, O., Lundberg, A., Burman, L. G., Akerlund, T. & Svenungsson, B. (2006). Antimicrobial susceptibility pattern of Clostridium difficile and its relation to PCR ribotypes in a Swedish University hospital. Antimicrob Agents Chemother 50, 1890-1892.
5. Barbut, F., Decré, D., Lalande, V., Burghoffer, B., Noussair, L., Gigandon, A., Espinasse, F., Raskine, L., Robert, J. & other authors (2005). Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains. J Med Microbiol 54, 181-185.
6. Bidet, P., Lalande, V., Salauze, B., Burghoffer, B., Avesani, V., Delmée, M., Rossier, A., Barbut, F. & Petit, J. C. (2000). Comparison of PCR-ribotyping, arbitrarily primed PCR, and pulsed-field gel electrophoresis for typing Clostridium difficile. J Clin Microbiol 38, 2484-2487.
7. Brazier, J. S. (2001). Typing of Clostridium difficile. Clin Microbiol Infect 7, 428-431.
8. Brazier, J. S., Fawley, W., Freeman, J. & Wilcox, M. H. (2001). Reduced susceptibility of Clostridium difficile to metronidazole. J Antimicrob Chemother 48, 741-742.
9. Brown, R., Collee, J. G. & Poxton, I. R. (1996). Bacteroides, Fusobacterium and other Gram-negative anaerobic rods; anaerobic cocci; identification of anaerobes. In Mackie and McCartney's Practical Medical Microbiology, pp. 501-519. Edited by J. G. Collee, A. G. Fraser, B. P. Marmion & A. Simmonds. Edinburgh: Churchill Livingstone.
10. Collier, M. C., Stock, F., Degirolami, P. C., Samore, M. H. & Cartwright, C. P. (1996). Comparison of PCR-based approaches to molecular epidemiologic analysis of Clostridium difficile. J Clin Microbiol 34, 1153-1157.
11. Drummond, L. J., McCoubrey, J., Smith, D. G., Starr, J. M. & Poxton, I. R. (2003). Changes in sensitivity patterns to selected antibiotics in Clostridium difficile in geriatric in-patients over an 18-month period. J Med Microbiol 52, 259-263.
12. Farrow, K. A., Lyras, D. & Rood, J. I. (2001). Genomic analysis of the erythromycin resistance element Tn5398 from Clostridium difficile. Microbiology 147, 2717-2728.
13. Geric, B., Johnson, S., Gerding, D. N., Grabnar, M. & Rupnik, M. (2003). Frequency of binary toxin genes among Clostridium difficile strains that do not produce large clostridial toxins. J Clin Microbiol 41, 5227-5232.
14. Geric, B., Rupnik, M., Gerding, D. N., Grabnar, M. & Johnson, S. (2004). Distribution of Clostridium difficile variant toxinotypes and strains with binary toxin genes among clinical isolates in an American hospital. J Med Microbiol 53, 887-894.
15. Health Protection Agency (2006). Clostridium difficile: findings and recommendations from a review of the epidemiology and a survey of Directors of Infection Prevention and Control in England. http:// www.hpa.org.uk/infections/topics_az/clostridium_difficile/documents/ Clostridium_difficile_survey_fIndings_recommendations.pdf
16. Hoogkamp-Korstanje, J. A. A. & Roelofs-Willemse, J. (2000). Comparative in vitro activity of moxifloxacin against Gram-positive clinical isolates. J Antimicrob Chemother 45, 31-39.
17. Hubert, B., Loo, V. G., Bourgault, A. M., Poirier, L., Dascal, A., Fortin, E., Dionne, M. & Lorange, M. (2007). A portrait of the geographic dissemination of the Clostridium difficile North American Pulsed-Field Type 1 strain and the epidemiology of C. difficile-associated disease in Quebec. Clin Infect Dis 44, 238-244.
18. John, R. & Brazier, J. S. (2005). Antimicrobial susceptibility of polymerase chain reaction ribotypes of Clostridium difficile commonly isolated from symptomatic hospital patients in the UK. J Hosp Infect 61, 11-14.
19. Johnson, S. & Gerding, D. N. (1998). Clostridium difficile-associated diarrhea. Clin Infect Dis 26, 1027-1034.
20. Johnson, S., Sambol, S. P., Brazier, J. S., Delmee, M., Avesani, V., Merrigan, M. M. & Gerding, D. N. (2003). International typing study of toxin A-negative, toxin B-positive Clostridium difficile variants. J Clin Microbiol 41, 1543-1547.
21. Kelly, C. P. & LaMont, J. T. (1998). Clostridium difficile infection. Annu Rev Med 49, 375-390.
22. Kuijper, E. J., Coignard, B. & Tull, P. (2006a). Emergence of Clostridium difficile-associated disease in North America and Europe. The ESCMID Study Group for Clostridium difficile and EU Member States and the European Centre for Disease Prevention and Control. Clin Microbiol Infect 12 (Suppl. 6), 2-18.
23. Kuijper, E. J., van den Berg, R. J., Debast, S., Visser, C. E., Veenendaal, D., Troelstra, A., van der Kooi, T., van den Hof, S. & Notermans, D. W. (2006b). Clostridium difficile ribotype 027, toxinotype III, the Netherlands. Emerg Infect Dis 12, 827-830.
24. Leroi, M. J., Siarakas, S. & Gottlieb, T. (2002). Etest susceptibility testing of nosocomial Clostridium difficile isolates against metronidazole, vancomycin, fusidic acid and novel agents moxifloxacin, gatifloxacin and linezolid. Eur J Clin Microbiol Infect Dis 21, 72-74.
25. Martirosian, G., Kuipers, S., Verburgh, H., van Belkum, A. & Meisel-Mikolajezik, F. (1995). PCR ribotyping and arbitrarily primed PCR for typing strains of Clostridium difficile from a Polish maternity hospital. J Clin Microbiol 33, 2016-2021.
26. McCoubrey, J. (2002). The epidemiology of Clostridium difficile in a geriatric unit. PhD thesis, Univiversity of Edinburgh, UK.
27. McCoubrey, J., Starr, J. M., Martin, H. J. & Poxton, I. R. (2003). Clostridium difficile in a geriatric unit: prospective epidemiological study employing a novel S-layer typing method. J Med Microbiol 52, 573-578.
28. McDonald, L. C., Killgore, G. E., Thompson, A., Owens, R. C., Kazakova, S. V., Sambol, S. P., Johnson, S. & Gerding, D. N. (2005). An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 353, 2433-2441.
29. NCCLS (2001). Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria, 5th edn. Approved standard M11-A5. Wayne, PA: National Committee for Clinical Laboratory Standards.
30. O'Neill, G. L., Ogunsola, F. T., Brazier, J. S. & Duerden, B. I. (1996). Modification of a PCR ribotyping method for application as a routine typing scheme for Clostridium difficile. Anaerobe 2, 205-209.
31. Peláez, T., Alcala, L., Alonso, R., Martín-Lopez, A., Garcia-Arias, V., Marín, M. & Bouza, E. (2005). In vitro activity of ramoplanin against Clostridium difficile, including strains with reduced susceptibility to vancomycin or with resistance to metronidazole. Antimicrob Agents Chemother 49, 1157-1159.
32. Pituch, H., Rupnik, M., Obuch-Woszczatynski, P., Grubesic, A., Meisel-Mikoiajczyk, F. & tuczak, M. (2005). Detection of binary-toxin genes (cdtA and cdtB) among Clostridium difficile strains isolated from patients with C. difficile-associated diarrhoea (CDAD) in Poland. J Med Microbiol 54, 143-147.
33. B) type resistance. J Med Microbiol 55, 207-213.
34. Rotimi, V. O., Jamal, W. Y., Mokaddas, E. M., Brazier, J. S., Johny, M. & Duerden, B. I. (2003). Prevalent PCR ribotypes of clinical and environmental strains of Clostridium difficile isolated from intensive-therapy unit patients in Kuwait. J Med Microbiol 52, 705-709.
35. Rupnik, M. (2001). How to detect Clostridium difficile variant strains in a routine laboratory. Clin Microbiol Infect 7, 417-420.
36. Rupnik, M., Braun, V., Soehn, F., Jane, M., Hofstetter, M., Laufenberg-Feldmann, R. & von Eichel-Streiber, C. (1997). Characterization of polymorphisms in the toxin A and B genes of Clostridium difficile. FEMS Microbiol Lett 148, 197-202.
37. Rupnik, M., Avesani, V., Jane, M., von Eichel-Streiber, C. & Delmée, M. (1998). A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates. J Clin Microbiol 36, 2240-2247.
38. Rupnik, M., Brazier, J. S., Duerden, B. I., Grabnar, M. & Stubbs, S. L. (2001). Comparison of toxinotyping and PCR ribotyping of Clostridium difficile strains and description of novel toxinotypes. Microbiology 147, 439-447.
39. Rupnik, M., Kato, N., Grabnar, M. & Kato, H. (2003a). New types of toxin A-negative, toxin B-positive strains among Clostridium difficile isolates from Asia. J Clin Microbiol 41, 1118-1125.
40. Rupnik, M., Grabnar, M. & Geric, B. (2003b). Binary toxin producing Clostridium difficile strains. Anaerobe 9, 289-294.
41. Spigaglia, P. & Mastrantonio, P. (2002). Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates. J Clin Microbiol 40, 3470-3475.
42. Spigaglia, P. & Mastrantonio, P. (2004). Comparative analysis of Clostridium difficile clinical isolates belonging to different genetic lineages and time periods. J Med Microbiol 53, 1129-1136.
43. Stubbs, S. L. J., Brazier, J. S., O'Neill, G. L. & Duerden, B. I. (1999). PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J Clin Microbiol 37, 461-463.
44. Stubbs, S., Rupnik, M., Gibert M., Brazier, J., Duerden, B. & Popoff, M. (2000). Production of an actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile. FEMS Microbiol Lett 186, 307-312.
45. Tasteyre, A., Karjalainen, T., Avesani, V., Delmee, M., Collignon, A., Bourlioux, P. & Barc, M. C. (2000). Phenotypic and genotypic diversity of the flagellin gene (fliC) among Clostridium difficile isolates from different serogroups. J Clin Microbiol 38, 3179-3186.
46. Urban, E., Brazier, J. S., Soki, J., Nagy, E. & Duerden, B. (2001). PCR ribotyping of clinically important Clostridium difficile strains from Hungary. J Med Microbiol 50, 1082-1086.
47. Wilcox, M. H., Fawley, W., Freeman, J. & Brayson, J. (2000). In vitro activity of new generation fluoroquinolones against genotypically distinct and indistinguishable Clostridium difficile isolates. J Antimicrob Chemother 46, 551-555.